Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruomeng Li

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Cancer Medicine|February 29, 2020
Development and validation of a novel nomogram for pretreatment prediction of liver metastasis in pancreatic cancerShangxiang Chen, Shaojie Chen, Guoda Lian, et al.
Translational Neurodegeneration|May 8, 2022
Melatonin ameliorates tau-related pathology via the miR-504-3p and CDK5 axis in Alzheimer's diseaseDongmei Chen, Guihua Lan, Ruomeng Li, et al.
ACS Chemical Neuroscience|December 1, 2022
MiR-191-5p Attenuates Tau Phosphorylation, Aβ Generation, and Neuronal Cell Death by Regulating Death-Associated Protein Kinase 1Long Wang, Xindong Shui, Mi Zhang, et al.
International Journal of Molecular Sciences|July 27, 2022
miR-143-3p Inhibits Aberrant Tau Phosphorylation and Amyloidogenic Processing of APP by Directly Targeting DAPK1 in Alzheimer's DiseaseLong Wang, Xindong Shui, Yingxue Mei, et al.
International Journal of Biological Sciences|May 20, 2026
A Novel PROTAC Confers a Dual Benefit Against Amyloid and Tau Pathology in Alzheimer's Disease via DAPK1 DegradationRuomeng Li, Jing Yao, Wen Peng, et al.
Archives of Pharmacal Research|October 7, 2023
Death-associated protein kinase 1 phosphorylates MDM2 and inhibits its protein stability and functionMi Zhang, Xindong Shui, Xiaoqing Zheng, et al.
Molecular Neurodegeneration|November 22, 2025
Death-associated protein kinase 1-dependent SENP1 degradation increases tau SUMOylation and leads to cognitive dysfunction in a mouse model for tauopathyXindong Shui, Xiaoqing Zheng, Jinfeng Wu, et al.
Journal of Ethnopharmacology|June 30, 2025
Saikosaponin C ameliorates tau-related pathology by modulating oxidative stress and MAPK axis in Alzheimer's diseaseDongmei Chen, Ruomeng Li, Fei She, et al.
Journal of Hepatology|September 1, 2024
Identification and functional validation of miR-190b-5p and miR-296-3p as novel therapeutic attenuators of liver fibrosisJovana Markovic, Ruomeng Li, Rajendra Khanal, et al.
Journal of Hepatology|April 10, 2022
Corrigendum to 'Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model' [J Hepatol (2021) 1420-1433]Taihua Yang, Marion Poenisch, Rajendra Khanal, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Cancer Medicine|February 29, 2020
Development and validation of a novel nomogram for pretreatment prediction of liver metastasis in pancreatic cancerShangxiang Chen, Shaojie Chen, Guoda Lian, et al.
Translational Neurodegeneration|May 8, 2022
Melatonin ameliorates tau-related pathology via the miR-504-3p and CDK5 axis in Alzheimer's diseaseDongmei Chen, Guihua Lan, Ruomeng Li, et al.
ACS Chemical Neuroscience|December 1, 2022
MiR-191-5p Attenuates Tau Phosphorylation, Aβ Generation, and Neuronal Cell Death by Regulating Death-Associated Protein Kinase 1Long Wang, Xindong Shui, Mi Zhang, et al.
International Journal of Molecular Sciences|July 27, 2022
miR-143-3p Inhibits Aberrant Tau Phosphorylation and Amyloidogenic Processing of APP by Directly Targeting DAPK1 in Alzheimer's DiseaseLong Wang, Xindong Shui, Yingxue Mei, et al.
International Journal of Biological Sciences|May 20, 2026
A Novel PROTAC Confers a Dual Benefit Against Amyloid and Tau Pathology in Alzheimer's Disease via DAPK1 DegradationRuomeng Li, Jing Yao, Wen Peng, et al.
Archives of Pharmacal Research|October 7, 2023
Death-associated protein kinase 1 phosphorylates MDM2 and inhibits its protein stability and functionMi Zhang, Xindong Shui, Xiaoqing Zheng, et al.
Molecular Neurodegeneration|November 22, 2025
Death-associated protein kinase 1-dependent SENP1 degradation increases tau SUMOylation and leads to cognitive dysfunction in a mouse model for tauopathyXindong Shui, Xiaoqing Zheng, Jinfeng Wu, et al.
Journal of Ethnopharmacology|June 30, 2025
Saikosaponin C ameliorates tau-related pathology by modulating oxidative stress and MAPK axis in Alzheimer's diseaseDongmei Chen, Ruomeng Li, Fei She, et al.
Journal of Hepatology|September 1, 2024
Identification and functional validation of miR-190b-5p and miR-296-3p as novel therapeutic attenuators of liver fibrosisJovana Markovic, Ruomeng Li, Rajendra Khanal, et al.
Journal of Hepatology|April 10, 2022
Corrigendum to 'Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model' [J Hepatol (2021) 1420-1433]Taihua Yang, Marion Poenisch, Rajendra Khanal, et al.
Pageof 8